SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-031397
Filing Date
2022-05-23
Accepted
2022-05-23 17:41:24
Documents
2
Period of Report
2022-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1629
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4066
  Complete submission text file 0001209191-22-031397.txt   7037
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Morrow Phuong Khanh (Reporting) CIK: 0001928989 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 22953036